KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Shares Outstanding: 2012-2025

Historic Shares Outstanding for Travere Therapeutics (TVTX) over the last 10 years, with Sep 2025 value amounting to $89.5 million.

  • Travere Therapeutics' Shares Outstanding rose 14.82% to $89.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.5 million, marking a year-over-year increase of 14.82%. This contributed to the annual value of $87.5 million for FY2024, which is 16.04% up from last year.
  • As of Q3 2025, Travere Therapeutics' Shares Outstanding stood at $89.5 million, which was up 0.40% from $89.1 million recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Shares Outstanding peaked at $89.5 million during Q3 2025, and registered a low of $60.4 million during Q1 2021.
  • For the 3-year period, Travere Therapeutics' Shares Outstanding averaged around $80.5 million, with its median value being $76.5 million (2024).
  • Data for Travere Therapeutics' Shares Outstanding shows a peak YoY spiked of 40.05% (in 2021) over the last 5 years.
  • Travere Therapeutics' Shares Outstanding (Quarterly) stood at $62.5 million in 2021, then climbed by 2.88% to $64.3 million in 2022, then climbed by 17.23% to $75.4 million in 2023, then climbed by 16.04% to $87.5 million in 2024, then grew by 14.82% to $89.5 million in 2025.
  • Its Shares Outstanding was $89.5 million in Q3 2025, compared to $89.1 million in Q2 2025 and $88.8 million in Q1 2025.